Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline Addition to IFN/RBV in HIV/HCV Coinfected Patients
NCT02008214Phase 4Unknown
- Sponsor
- Centro Universitario de Ciencias de la Salud
- Start
- Dec 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hepatitis C (HCV) comparing PTX Arm with Placebo Arm (2 arms). Primary endpoint: Sustained Virologic Response. Status: unknown.
02
Drugs
pentoxifylline
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02008214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008214.